Crescent Capital BDC Azioni (NASDAQ: CCAP)

Ultime notizie per Crescent Capital BDC (NASDAQ:CCAP) Azioni

Crescent Capital BDC

Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.

Crescent Capital BDC, Inc. - Common Stock

Crescent Capital BDC Inc

TRNR

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

VLCN

FCEL

Chardan Capital analyst Daniil Gataulin maintains Ocugen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCGN#NASDAQ">OCGN</a>) with a Buy and maintains $6 price target.

News

Price Target

Analyst Ratings

OCGN

Chardan Capital Maintains Buy on Ocugen, Maintains $6 Price Target

Chardan Capital analyst Matthew Barcus maintains Zura Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZURA#NASDAQ">ZURA</a>) with a Buy and lowers the price target from $14 to $12.

ZURA

Chardan Capital Maintains Buy on Zura Bio, Lowers Price Target to $12

Canaccord Genuity analyst Yuri Lynk upgrades Stantec (TSX:<a class="ticker" href="https://www.benzinga.com/stock/STN#TSX">STN</a>) from Hold to Buy and raises the price target from C$125 to C$135.

Upgrades

TSX:STN

Canaccord Genuity Upgrades Stantec to Buy, Raises Price Target to C$135

Wells Fargo analyst Andrew Bauch maintains Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) with a Overweight and raises the price target from $52 to $55.

AFRM

Wells Fargo Maintains Overweight on Affirm Holdings, Raises Price Target to $55

Loop Capital analyst Yun Kim maintains Dynatrace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DT#NYSE">DT</a>) with a Hold and raises the price target from $45 to $55.

Loop Capital Maintains Hold on Dynatrace, Raises Price Target to $55

GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>), SoFi Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>), Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), Cassava Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) and Anavex Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) are the top five trending tickers on Stocktwits Friday. Here&#8217;s a look at what grabbed <a href="https://www.benzinga.com/trading-ideas/24/11/41856335/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-42">retail investors&#8217; attention.</a>
GME GM-Meme: GameStop tops the list this week. The stock moved on heavy volume and zero fundamentals Friday, as the original meme-stock tends to do. Keith Gill, a.k.a. Roaring Kitty, dumped his Chewy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) shares at the <a href="https://www.benzinga.com/news/24/10/41614177/roaring-kitty-puts-chewy-stock-in-the-litter-box-gamestop-shares-move-higher-after-hours">end of October </a>and GameStop has climbed steadily since.&nbsp;
SOFI Surges: SoFi shares have climbed 17%<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41847971/jim-cramer-this-tech-stock-is-a-buy-sofi-technologies-is-good"> this week</a> as investors hope for deregulation under a second Trump presidency. The stock pumped on heavy volume and ended the day more than 9% higher. 
Read Next: <a href="https://www.benzinga.com/news/24/11/41781921/what-does-trumps-victory-mean-for-ev-giant-tesla-and-the-big-3-automakers">What Does Trump&#8217;s Victory Mean For EV Giant Tesla And The Big 3 Automakers?</a>
TSLA For President: Tesla shares blasted higher after Donald Trump won the presidential election. Tesla CEO Elon Musk joined Trump several times on the campaign trail and may even be appointed to a position in the administration.&nbsp;
Investors may also consider Trump's EV and tariff policy beneficial to Tesla, as both could potentially reduce competition for the U.S.-based EV giant. The stock has been up 30% since Tuesday, and its market cap has <a href="https://www.benzinga.com/news/management/24/11/41856784/elon-musks-wealth-tops-300-billion-as-teslas-market-cap-soars-above-1-trillion">now reached </a>more than $1 trillion. 
SAVA: Cassava Sciences is a frequent flier on the Stocktwits trending list. HC Wainwright &amp; Co. analyst Vernon Bernardino reiterated Cassava Sciences as a Buy and maintained an ambitious price target of $116 on Friday. The stock is currently trading at just under $27. 
AVXL: Anavex Life Sciences rounds out the list as another heavily-shorted biotech stock that moved on heavy volume, despite a lack of news. According to data from Benzinga Pro, 21.78% of shares are being sold short, and the stock saw more than triple its average trading volume on Friday. 
GME, SOFI, TSLA, SAVA, AVXL Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, GameStop shares closed up 6.1% at $24.88, SoFi shares closed up 9.33% at $13.01, Tesla shares closed up 8.19% at $321.22, Cassava Sciences shares closed up 6.55% at $27.00 and Anavex Life Sciences shares ended the day up 21% at $9.24 on Friday.&nbsp;
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41822473/trumps-potential-health-czar-robert-f-kennedy-jr-rattles-vaccine-stocks-shoot-first-reaction">Trump&#8217;s Potential &#8216;Health Czar&#8217; Robert F. Kennedy Jr. Rattles Vaccine Stocks: &#8216;Shoot First Reaction&#8217;</a></li>
</ul>
Image: Shutterstock

Biotech

Large Cap

Topics

Movers

General

AVXL

CHWY

SAVA

SOFI

TSLA

Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla?

Loop Capital analyst Alton Stump upgrades Domino's Pizza (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) from Hold to Buy and raises the price target from $419 to $559.

Loop Capital Upgrades Domino's Pizza to Buy, Raises Price Target to $559

Jones Trading analyst Jason Weaver maintains GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) with a Buy and raises the price target from $18.75 to $32.

Jones Trading Maintains Buy on GEO Group, Raises Price Target to $32

EF Hutton analyst Jason Kolbert maintains CytoSorbents (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSO#NASDAQ">CTSO</a>) with a Buy and maintains $10 price target.

CTSO

EF Hutton Maintains Buy on CytoSorbents, Maintains $10 Price Target

Telsey Advisory Group analyst Dana Telsey maintains Warby Parker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRBY#NYSE">WRBY</a>) with a Outperform and raises the price target from $19 to $22.

WRBY

Telsey Advisory Group Maintains Outperform on Warby Parker, Raises Price Target to $22

Rosenblatt analyst Kevin Cassidy maintains Ouster (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) with a Buy and maintains $17 price target.

OUST

Rosenblatt Maintains Buy on Ouster, Maintains $17 Price Target

Rosenblatt analyst Catharine Trebnick maintains RingCentral (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNG#NYSE">RNG</a>) with a Buy and maintains $45 price target.

Rosenblatt Maintains Buy on RingCentral, Maintains $45 Price Target

Rosenblatt analyst Catharine Trebnick maintains Fortinet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) with a Buy and raises the price target from $85 to $90.

FTNT

Rosenblatt Maintains Buy on Fortinet, Raises Price Target to $90

Planet 13 Holdings Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PLNH#OTC">PLNH</a>) reported Friday afternoon a strong revenue increase of 29.7% year-over-year for Q3 2024, reaching $32.2 million. The growth was fueled by the expansion into the Florida market and solid performance at its Illinois store. 
Despite the revenue boost, the company posted a net loss of $7.4 million; still a significant improvement from the $46.3 million net loss in Q3 2023.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.</li>
</ul>
<h3 class="wp-block-heading">Improved Margins&nbsp;</h3>
The company's gross profit rose to $16.7 million, up from $11.1 million in the same quarter last year. Gross margins also improved, reaching 51.9%, compared to 44.7% previously. Planet 13 attributed the margin growth to enhanced yields from cultivation and higher margin sales in <a href="https://www.benzinga.com/topic/florida-cannabis">Florida</a>.&nbsp;
Operating expenses dropped sharply by 66.4%, thanks to reduced impairment losses, signaling better cost management.
Read Also:<a href="https://www.benzinga.com/general/health-care/24/11/41843261/kentucky-gov-beshear-the-jury-is-no-longer-out-kentuckians-want-medical-cannabis"> Kentucky Gov. Beshear: &#8216;The Jury Is No Longer Out,&#8217; Kentuckians Want Medical Cannabis</a>
<h3 class="wp-block-heading">Adjusted EBITDA And Future Outlook</h3>
Planet 13 reported an adjusted EBITDA of $1.3 million, a substantial increase from $0.2 million in Q3 2023, highlighting improved operating leverage.&nbsp;
In spite of consumer spending challenges, co-CEO Bob Groesbeck<a href="https://www.globenewswire.com/us/news-release/2024/11/08/2977890/0/en/Planet-13-Announces-Q3-2024-Financial-Results.html"> pointed out </a>the strategic focus on cash flow and scaling its footprint.
"Despite Florida not moving forward with adult-use [cannabis legalization], we see a significant growth runway by expanding our store footprint and enhancing cultivation assets in the state. In addition to our<a href="https://www.benzinga.com/topic/florida-cannabis"> Florida operations</a>, we&#8217;re focused on driving growth by scaling our neighborhood store network and broadening the distribution of our HaHa edibles," said Larry Scheffler, co-CEO of Planet 13.
With $27.4 million in cash, up from $11.8 million at the end of 2023, Planet 13 is positioning itself for future growth. The company's expansion in Florida and recent acquisitions signal a commitment to broadening its market presence as it aims for profitability in 2025.
Read Next: <a href="https://www.benzinga.com/news/earnings/24/11/41843751/canopy-growth-q2-net-revenue-drops-9-yoy-projects-positive-earnings-ahead">Canopy Growth: Q2 Net Revenue Drops 9% YoY, Projects Positive Earnings Ahead</a>

Cannabis

Earnings

Management

Markets

PLNH

Planet 13 Slashes Costs 66%: Revenue Grows, Losses Shrink — Is This The Turning Point?

Rosenblatt analyst Catharine Trebnick maintains Five9 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVN#NASDAQ">FIVN</a>) with a Buy and raises the price target from $45 to $50.

FIVN

Rosenblatt Maintains Buy on Five9, Raises Price Target to $50

Rosenblatt analyst Barton Crockett maintains Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) with a Buy and lowers the price target from $48 to $46.

PINS

Rosenblatt Maintains Buy on Pinterest, Lowers Price Target to $46

Rosenblatt analyst Barton Crockett maintains Liberty Formula One Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONK#NASDAQ">FWONK</a>) with a Buy and raises the price target from $91 to $93.

FWONK

Rosenblatt Maintains Buy on Liberty Formula One Gr, Raises Price Target to $93

My 9.5% Income Portfolio - The View From The Top

Oppenheimer lists best stock ideas into the 2024 U.S. elections

Crescent Capital BDC: A Reliable Dividend Payer

Crescent Capital High Yielding Dividends Are Well-Covered Despite Interest Rate Sensitivity

Pivotal Moment For BDC Dividend Investors, Here Is What To Do

I'm Buying Up To 9% Yield For Recurring Income

CION Investment Corp: A Quality BDC Worth Buying, Although Upside May Be Limited

Crescent Capital: 10% Yield, Low Pay-Out Ratio, 10% NAV Discount (Rating Upgrade)

2 Small Cap, Growing BDCs That Could Be Great Income Additions To Your Portfolio

My 9.5% Income Portfolio - Fifty Shades Of Blue

AAPL

ALSN

ALTR

AMGN

AMRC

ARCC

AVGO

BBDC

BIZD

BXSL

CCAP

CION

COST

CSCO

CSWC

DXCM

FDUS

FIVE

GAIN

GAINL

GAINN

GAINZ

GBDC

GECC

GECCI

GECCM

GECCO

GECCZ

GLAD

GLADZ

GOOG

GPRE

HUBS

JEPI

JEPQ

KNSL

LRFC

MAIN

NVDA

OBDC

OBDE

OCSL

OXLC

PBDC

PFLT

PNNT

QYLD

RYLD

SDOW

SKWD

SNAP

SPXU

SQQQ

TCPC

TPVG

TQQQ

TSCO

TSLX

UDOW

UPRO

USOI

WHFCL

XFLT

XYLD

Press Releases

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2023 Financial Results

Crescent Capital BDC, Inc. Reports December 31, 2023 Financial Results; Declares a First Quarter Regular Dividend of $0.41 Per Share and a Fourth Quarter Supplemental Dividend of $0.10 Per Share

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its First Quarter Ended March 31, 2024 Financial Results

Crescent Capital BDC, Inc. Reports First Quarter Net Investment Income Per Share of $0.63 and NAV Per Share of $20.28; Increases Quarterly Dividend

Crescent Capital BDC, Inc. to Host Analyst & Investor Day on June 11, 2024

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Second Quarter Ended June 30, 2024 Financial Results

Crescent Capital BDC, Inc. Reports Second Quarter 2024 Earnings Results; Declares a Third Quarter Base Dividend of $0.42 Per Share, and a Second Quarter Supplemental Dividend of $0.09 Per Share

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Third Quarter Ended September 30, 2024 Financial Results

Associated Capital Group, Inc. Common Stock

Associated Cap Gr

AlTi Global

Barings BDC

Bain Capital Specialty Finance, Inc. Common Stock

Bain Capital Specialty

Bridge Investment Group Holdings Inc. Class A Common Stock

Bridge Investment Group

BrightSphere Investment Group Inc. Common Stock

BrightSphere Investment

Carlyle Secured Lending, Inc. - Closed End Fund

Carlyle Secured Lending

CION Invt

Capital Southwest Corporation - Common Stock

Capital Southwest

Diamond Hill Investment Group, Inc. - Class A Common Stock

Diamond Hill Investment

Fidus Investment Corporation - Closed End Fund

Fidus Investment

Gladstone Investment Corporation - Business Development Company

Gladstone Inv

GCM Grosvenor Inc. - Class A Common Stock

GCM Grosvenor

Gladstone Capital Corporation - Closed End Fund

Gladstone Cap

Innventure

Nuveen Churchill Direct Lending Corp. Common Stock

Nuveen Churchill Direct

Noah Holdings Limited American Depositary Shares

Noah Holdings

PennantPark Floating Rate Capital Ltd. Common Stock

PennantPark Floating Rate

PennantPark Investment Corporation Common Stock

Pennant Park Investment

Palmer Square Capital BDC Inc. Common Stock

Palmer Square Capital BDC

Runway Growth Finance Corp. - Common Stock

Runway Gwth Fin

SLR Inv

BlackRock TCP Capital Corp. - Closed End Fund

BlackRock TCP Cap

Trinity Cap

Vinci Partners Investments Ltd. - Class A Common Shares

Vinci Partners Inv

Comments

Crescent Capital BDC

Notizie

Ultime notizie per Crescent Capital BDC (NASDAQ:CCAP) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO